Abstract
Introduction
Diabetes is recognized as one of the major risk factors for the development of cardiovascular disease (CVD) both in men and women (1, 2) . There is a large body of evidence showing increased mortality due to CVD, especially ischemic heart disease (IHD) in patients with diabetes compared with the general population (3) (4) (5) (6) . Unfortunately, these studies have often pooled patients with type 1 and type 2 diabetes, thus possibly masking any potential differences in mortality rates between these two populations. While a few large, long-term cohort studies examined the sex differences in mortality rates in patients with T1D, the reports show great disparity in their conclusions and rarely examined mortality rates specifically due to IHD, but rather overall CVD (3, (7) (8) (9) (10) (11) . Another frequently understudied topic has been that the mortality rates due to IHD have not been stratified by age at onset of T1D. Our recent observations suggested that the long-term risk of developing microvascular complications are not only different between men and women, but the risk of microvascular complications are greatly dependent on the age at onset of T1D (12) . While others have also shown that the age at onset of diabetes plays a critical role in determining the overall cumulative risk of developing organ complications associated with diabetes (13) (14) (15) , few studies have recognized that this effect may be sex-specific.
Thus, the aim of the present study was to examine sex differences in mortality due to IHD according to the age at onset of diabetes in a cohort of 17,306 Finnish patients with T1D.
Methods
The study population included 17,306 Finnish patients diagnosed with T1D between 1970 and 1999 before the age 30 years. Follow-up started from the time of diagnosis of T1D and ended either at the time of death or at the end of 2011. The patients were identified from the Drug Reimbursement Register (DRR) of Finland. Since insulin for the treatment of type 1 diabetes has been free of charge in Finland since 1964, the DRR register includes all patients in Finland receiving insulin for T1D.
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Diabetes Care T1D was verified in the majority (74%) of patients as reported previously (16) (17) (18) (19) . The classification of the type of diabetes in the rest (26%) of the patients was achieved following the procedure previously described (19) . Briefly, the data on the patients from the DRR were linked to the Hospital Discharge Register (HDR) maintained by the National Institute for Health and
Welfare. The HDR covers all hospital discharges, nationwide since 1972, and includes up to four hospital discharge diagnoses (ICD-codes) for each patient ever been admitted to a hospital. Those cases in the HDR with a code indicating possible secondary diabetes were excluded. The ICDcodes used to define the patient as having T1D were: 2500B-2508B, E10.0-E10.9 or O24.0. Vital status and causes of death were obtained from the Finnish Cause of Death Register (CDR). The register links were carried out by using personal identification codes. For diagnosis of IHD, ICD-8, ICD-9 and ICD-10 codes 410-414 or I20-I25 were used.
Statistical methods
Crude age-specific mortality rates were calculated for each 5-year age group after 20 years of age and expressed per 100,000 person years. Standardized mortality ratios (SMRs) were calculated as the ratio of the number of observed deaths and the number of expected deaths. The number of expected deaths due to IHD was calculated by multiplying the number of person-years at risk by the 5-year age group by calendar year-specific and sex-specific IHD mortality rates in the Finnish background population drawn from Statistics Finland and the National Institute for Health and Welfare. SMRs were calculated for the total cohort and separately for the early-onset (0-14 years, n=10,492) and late-onset (15-29 years, n=6,814) cohorts stratified by sex and attained age.
The SMR analysis was based on IHD as the primary cause of death in order to be consistent with the method used in the background population. However, crude mortality rates were calculated based on whether IHD was either a major or contributory cause of death.
Cumulative mortality was evaluated using the Kaplan-Meier method and differences between the groups were compared with the log-rank test. The impact of sex, age at onset stratified as early-onset and late-onset groups, diagnosis year of diabetes and duration of diabetes on the risk of dying from IHD was studied by applying the multivariate Poisson Regression models and corresponding mortality rate ratios (RR) were derived. Statistical analyses were performed using SAS 9.2 version (SAS Institute Inc, Cary, NC, USA).
This study was approved by the Ethical Committee of the National Institute for Health and Welfare, Finland. Table 1 shows the characteristics of the study population. (Table 2 ).
Results
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The numbers of deaths from IHD in the patients with T1D were compared with the numbers of deaths from IHD in the background population and the SMRs were calculated. For the total (early-and late-onset pooled) cohort, the SMR was 7.2 (95% CI, 6.4-8.0) ( Table 3 ). In contrast to the crude mortality rates, the SMRs were higher in women, 21.6 (95% CI 17.2-27.0) compared with 5.8 (95% CI 5.1-6.6) for men. When stratified by the age at onset of diabetes, the SMR was considerably higher in patients with early-onset 16.9 (95% CI 13.5-20.9) compared to late-onset diabetes, 5.9 (95% CI 5.2-6.8). In both the late-and the early onset cohorts, there was a striking difference in the SMRs between women and men, and this was especially evident in the early-onset cohort, where the SMR for women was 52.8 (95% CI 36.3-74.5) compared to 12.1 (95% CI 9.2-15.8) for men. This higher risk of death from IHD compared with the background population was evident in all women, regardless of their age. However, the most pronounced effect was seen in women in the early onset cohort under the age of 40 years, which were 83-times more likely to die from IHD than the age-matched women in the background population. This compares with a 37-times higher risk of death from IHD in women over the age of 40 years. The corresponding SMRs for men in the <40 years and ≥40 years of age group were 19.4 and 8.5, respectively. In contrast to the early onset cohort, the SMR in the late onset cohort was higher in women ≥40 years compared with <40 years of age, being 16.8 (95% CI 12.5-22.3) and 6.4 (95% CI 1.1-21.2), respectively, ( Table 2 ). In contrast, in the late onset cohort, the SMRs were no different between men in the <40 years and ≥40 years age groups.
Overall the 40-year cumulative mortality for IHD was 8.8% (95% CI 7.9-9.7) in all patients (data not shown). Figure 1 compares cumulative mortality rates from IHD in the earlyonset and late-onset cohorts according to sex. The 40-year cumulative IHD mortality in the earlyonset cohort was 6.3% (95% CI 4.8-7.8) for men and 4.5% (95% CI 3.1-5.9) for women ( Figure   1A , p=0.009, log-rank-test). In the late onset cohort the corresponding cumulative mortality rates 
Discussion
This study provides novel information about mortality rates and SMRs from IHD taking into account sex and age at onset of diabetes. The major findings of the present study include that women with early-onset T1D are exceptionally vulnerable to die from IHD. This is especially evident in those women diagnosed with T1D during the pre-pubertal and pubertal years. Crude mortality rates were rather similar for women compared with men highlighting the loss of cardioprotection in women. These observations suggest that sex, age at onset of T1D are important determinants of mortality from IHD. The fact that IHD is a major cause of death in patients with T1D, accounting for about a quarter of all deaths has previously been reported by many others (3-
Although men of all ages have greater crude mortality regardless of the age at onset of T1D compared with women, our study shows that mortality from IHD attributable to diabetes is much more pronounced in women than men. These observations highlight the loss of the female sex as a protective factor in the setting of diabetes. Greater relative risk of mortality from IHD in women with T1D has also been observed by others (3, 7, 9, 20) , albeit, these studies did not stratify by age at onset of diabetes. This high risk of mortality in women may not be so surprising since in the general population, pre-menopausal women exhibit a low risk of CVD and also low relative mortality due to CVD compared with age matched men (21, 22) . It is generally thought that estrogen, as the predominant hormone in females offers cardioprotection in women of reproductive age, since the loss of ovarian hormones after menopause increases the risk of CVD. Thus, it is conceivable that one of the underlying reasons for the loss of the female sex as protective factor against the development of CVD in the setting of diabetes may be loss of ovarian hormones.
Indeed, women with type 1 diabetes have been shown to have reduced levels of plasma estradiol One of the novelties of the present studies is that the risk of death from IHD is highly dependent on the age at onset of T1D. Our data show that the SMR was considerably higher in early-onset (0-14 years) compared to late-onset (15-29 years) T1D in both sexes. The longer duration of diabetes in the early onset diabetes cohort may partly explain the higher mortality since those patients develop IHD at earlier ages when there are fewer cases of IHD deaths in the background population. Interestingly, in the early-onset of diabetes cohort, the relative risk of dying from IHD was greatest in women under 40 years of age, while in the late-onset cohort, the greatest risk was observed in women over 40 years of age. While the latter may be explained through changes in the hormonal profile as these women may be entering menopause, the risk in women under 40 years of age in the early-onset of diabetes cohort is more difficult to explain.
However, it is conceivable that even younger women with T1D experience hormonal changes that may contribute to the risk for IHD in these women. Indeed, studies have shown that women with T1D often present with hormonal disturbances leading to menstrual abnormalities and infertility (24, 25) .
The strength of the present study is that the patients included in the study consisted of a population-based cohort of the patients with known type 1 diabetes and their causes of death were obtained from the Finnish Cause of Death Register. Thus, the identification of the patients with diabetes was not done using death certificates, which is problematic since diabetes is consistently under-recorded as the immediate cause of death (26) . Another strength of the study is that, to our knowledge, this is the first study that includes such a large number of patients as well as the long follow-up period (433,782 person-years) in examining risk of mortality from IHD according to the age at onset of diabetes and sex. Our study is a register study and has the limitations connected with this type of research. Some cases of T2D might have been falsely classified as T1D, but because we used several sources of information, the number of such cases is likely to be very small and therefore the effect on the results should be small. With regard to deaths due to IHD, the reliability of the Finnish Causes of Death Register has been considered to be high (27) . However, since the patients with T1D are often multi-diseased, IHD is not always the major cause of death.
Therefore, we took into consideration IHD also as a contributory cause of death. Our study was also unable to examine the relationship between mortality and menopausal status of women.
In summary, our study finds that the risk of dying from IHD is high in both women and men diagnosed with T1D at a younger age. While men still had higher crude mortality rates compared with women, the increased risk of dying from IHD due to T1D was more pronounced in women. These observations underscore the importance of identifying risk factors early in women and more aggressive treatment following diagnosis. Table 3 . Age-specific standardized mortality ratios (SMRs) for ischemic heart disease between women and men according to age at onset (early-onset 0-14 years, late-onset 15-29 years) and attained age. 
